Figure 3. 1st MSA patient on nasal foralumab

Figure 3. 1st MSA patient on nasal foralumab

Marked reduction in basal ganglia uptake following nasal foralumab

Format

PNG

Quelle:

Tiziana Life Sciences Ltd.

Downloads